东富龙T淋巴细胞培养基在鑫湾生物免疫细胞项目上获得优异的表现，无论是纯度还是细胞扩增效果均呈现显著优势，东富龙培养基未来将作为鑫湾生物免疫细胞项目首选培养基，进入细胞治疗管线产品的临床试验及上市申报。
东富龙集团目前已全面完成四大关键耗材产品的布局，包括一次性组件、培养基、填料以及过滤器。为了进一步增强公司在生物制药供应链中的影响力，生命科学事业部特别设立了生物工艺耗材团队，此团队旨在为广大生物制药和生命科学领域的客户提供量身定制的专业工艺解决方案和耗材技术支持。
Exciting News!
Discover how Tofflon's ATF technology simplifies and enhances cell cultivationATF
FDA 21 CFR Part 11 and EU Annex 11
Bioreactors and Serum-Free Medium Vaccine development and manufacturing have experienced tremendous growth in recent decades.
Tofflon Team (Fred Wu, David Luo, Way Wen, Anna Yakhutina, Irina Galushko, Elmira Amineva, Max Yin) had participated in the 7th International Scientific Practical Conference
Unlocking the Potential of CHO Cells for Bioprocessing Chinese hamster ovary (CHO) cells have become the foremost platform for manufacturing therapeutic antibodies and proteins.
